These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

412 related articles for article (PubMed ID: 9616216)

  • 41. New insights into the interactions between T-cell costimulatory blockade and conventional immunosuppressive drugs.
    Sho M; Sandner SE; Najafian N; Salama AD; Dong V; Yamada A; Kishimoto K; Harada H; Schmitt I; Sayegh MH
    Ann Surg; 2002 Nov; 236(5):667-75. PubMed ID: 12409674
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Distinct mechanisms for the induction and maintenance of allograft tolerance with CTLA4-Fc treatment.
    Tran HM; Nickerson PW; Restifo AC; Ivis-Woodward MA; Patel A; Allen RD; Strom TB; O'Connell PJ
    J Immunol; 1997 Sep; 159(5):2232-9. PubMed ID: 9278311
    [TBL] [Abstract][Full Text] [Related]  

  • 43. TLR agonists abrogate costimulation blockade-induced prolongation of skin allografts.
    Thornley TB; Brehm MA; Markees TG; Shultz LD; Mordes JP; Welsh RM; Rossini AA; Greiner DL
    J Immunol; 2006 Feb; 176(3):1561-70. PubMed ID: 16424185
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Induction of immunologic tolerance to cardiac allograft by simultaneous blockade of inducible co-stimulator and cytotoxic T-lymphocyte antigen 4 pathway.
    Kosuge H; Suzuki J; Gotoh R; Koga N; Ito H; Isobe M; Inobe M; Uede T
    Transplantation; 2003 Apr; 75(8):1374-9. PubMed ID: 12717233
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Blockade of CD40-CD154 costimulatory pathway promotes survival of allogeneic corneal transplants.
    Qian Y; Boisgerault F; Benichou G; Dana MR
    Invest Ophthalmol Vis Sci; 2001 Apr; 42(5):987-94. PubMed ID: 11274076
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Coronary arteriosclerosis after T-cell-mediated injury in transplanted mouse hearts: role of interferon-gamma.
    Nagano H; Libby P; Taylor MK; Hasegawa S; Stinn JL; Becker G; Tilney NL; Mitchell RN
    Am J Pathol; 1998 May; 152(5):1187-97. PubMed ID: 9588888
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Anti-CD4 monoclonal antibody-induced allograft tolerance in rats despite persistence of donor-reactive T cells.
    Lehmann M; Graser E; Risch K; Hancock WW; Müller A; Kuttler B; Hahn HJ; Kupiec-Weglinski JW; Brock J; Volk HD
    Transplantation; 1997 Oct; 64(8):1181-7. PubMed ID: 9355837
    [TBL] [Abstract][Full Text] [Related]  

  • 48. NOD mice have a generalized defect in their response to transplantation tolerance induction.
    Markees TG; Serreze DV; Phillips NE; Sorli CH; Gordon EJ; Shultz LD; Noelle RJ; Woda BA; Greiner DL; Mordes JP; Rossini AA
    Diabetes; 1999 May; 48(5):967-74. PubMed ID: 10331399
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Prolonged allograft survival in anti-CD4 antibody transgenic mice: lack of residual helper T cells compared with other CD4-deficient mice.
    Han WR; Zhan Y; Murray-Segal LJ; Brady JL; Lew AM; Mottram PL
    Transplantation; 2000 Jul; 70(1):168-74. PubMed ID: 10919596
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Prolongation of corneal allograft survival by CTLA4-FasL in a murine model.
    Shi W; Chen M; Xie L
    Graefes Arch Clin Exp Ophthalmol; 2007 Nov; 245(11):1691-7. PubMed ID: 17541621
    [TBL] [Abstract][Full Text] [Related]  

  • 51. IFN-gamma production is specifically regulated by IL-10 in mice made tolerant with anti-CD40 ligand antibody and intact active bone.
    Yin D; Dujovny N; Ma L; Varghese A; Shen J; Bishop DK; Chong AS
    J Immunol; 2003 Jan; 170(2):853-60. PubMed ID: 12517950
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A synthetic CD4-CDR3 peptide analog enhances skin allograft survival across a MHC class II barrier.
    Koch U; Choksi S; Marcucci L; Korngold R
    J Immunol; 1998 Jul; 161(1):421-9. PubMed ID: 9647252
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Inhibition of transplant rejection following treatment with anti-B7-2 and anti-B7-1 antibodies.
    Lenschow DJ; Zeng Y; Hathcock KS; Zuckerman LA; Freeman G; Thistlethwaite JR; Gray GS; Hodes RJ; Bluestone JA
    Transplantation; 1995 Nov; 60(10):1171-8. PubMed ID: 7482727
    [TBL] [Abstract][Full Text] [Related]  

  • 54. B7-dependent T-cell costimulation in mice lacking CD28 and CTLA4.
    Mandelbrot DA; Oosterwegel MA; Shimizu K; Yamada A; Freeman GJ; Mitchell RN; Sayegh MH; Sharpe AH
    J Clin Invest; 2001 Apr; 107(7):881-7. PubMed ID: 11285307
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Transplantation tolerance induced by CTLA4-Ig.
    Pearson TC; Alexander DZ; Winn KJ; Linsley PS; Lowry RP; Larsen CP
    Transplantation; 1994 Jun; 57(12):1701-6. PubMed ID: 8016872
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Prevention of chronic rejection in mouse aortic allografts by combined treatment with CTLA4-Ig and anti-CD40 ligand monoclonal antibody.
    Sun H; Subbotin V; Chen C; Aitouche A; Valdivia LA; Sayegh MH; Linsley PS; Fung JJ; Starzl TE; Rao AS
    Transplantation; 1997 Dec; 64(12):1838-43. PubMed ID: 9422428
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Monoclonal antibody treatment to prolong the secondary cardiac allograft survival in alloantigen-primed mice.
    Xie B; Chen J; Wang F; Lan T; Wang Y; Xia J; Li Z; Xie Q; Huang R; Qi Z
    Scand J Immunol; 2010 May; 71(5):345-52. PubMed ID: 20500685
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Specific immunosuppression of corneal allograft rejection by combination of anti-VLA-4 and anti-LFA-1 monoclonal antibodies in mice.
    Hori J; Isobe M; Yamagami S; Mizuochi T; Tsuru T
    Exp Eye Res; 1997 Jul; 65(1):89-98. PubMed ID: 9237869
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Anti-TCR mAb induces peripheral tolerance to alloantigens and delays islet allograft rejection in autoimmune diabetic NOD mice.
    Deng R; Khattar M; Xie A; Schroder PM; He X; Chen W; Stepkowski SM
    Transplantation; 2014 Jun; 97(12):1216-24. PubMed ID: 24854475
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Improved survival of biolistically transfected mouse islet allografts expressing CTLA4-Ig or soluble Fas ligand.
    Gainer AL; Suarez-Pinzon WL; Min WP; Swiston JR; Hancock-Friesen C; Korbutt GS; Rajotte RV; Warnock GL; Elliott JF
    Transplantation; 1998 Jul; 66(2):194-9. PubMed ID: 9701263
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.